| name | KSB-D05-K0016 |
| description | Protocol Safety Design: Primary safety endpoints, stopping rules, dose modification protocols, safety run-in periods... |
| version | 1.0.0 |
| domain | D05 |
| domain_name | Clinical Trials PV |
| type | Knowledge |
| proficiency_level | L3 |
| bloom_level | apply |
| triggers | ["explain protocol safety design","what is protocol safety design","apply protocol safety design"] |
| epa_mapping | EPA-02, EPA-04, EPA-08 |
| cpa_mapping | CPA-01, CPA-07 |
| regulatory_refs | EMA-REG-004, ICH-E6 |
KSB-D05-K0016: Protocol Safety Design
Overview
Domain: D05 - Clinical Trials PV
Type: Knowledge
Proficiency Level: L3 (Competent - Minimal supervision)
Bloom Level: Apply
Description
Primary safety endpoints, stopping rules, dose modification protocols, safety run-in periods
Context
- Major Section: Clinical Trial Regulatory Framework and Safety Requirements
- Section: Comprehensive Safety Planning Framework
EPA Mapping
- EPA-02:3004-3005
- EPA-04:3009-3010
- EPA-08:3018-3019
CPA Pathway
Regulatory References
Instructions
When this skill is activated, Claude should:
- Demonstrate L3 proficiency in protocol safety design
- Apply apply level cognitive skills to apply the topic
- Reference relevant regulatory guidance (EMA-REG-004, ICH-E6)
- Connect to related EPAs: EPA-02, EPA-04, EPA-08
Key Competencies
- Primary safety endpoints, stopping rules, dose modification protocols, safety run-in periods
Assessment Criteria
- Can apply core concepts independently
- Demonstrates understanding of regulatory context
- Applies knowledge appropriately to PV scenarios
Related Skills
- Other D05 skills in Comprehensive Safety Planning Framework
- Cross-domain integrations per DAG architecture
Generated from PV KSB Framework v1.0 | 2025-12-31